Amaryllis' RNA-seq library prep method exploits the phenomenon of nucleic acid "breathing" to insert adapters at the 5' end of RNA, which it says saves time and money.
With sequence data for thousands of cases in children and young adults, researchers identified tumor molecular subtypes that coincided with patients' genetic ancestry.
A new survey finds that confidence in science among US adults is increasingly polarized, the Associated Press says.
NPR reports that the US National Institutes of Health has transferred the last of its eligible former research chimpanzees to a sanctuary.
The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant.
Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization
In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more.
Biosplice will use Epic's liquid biopsy platform in several clinical trials, including for its Cirtuvivint investigative drug for solid tumors.
The firms were able to obtain high molecular weight DNA from 96 samples in just a few hours, with molecules ranging in size from 50 kb to more than 200 kb.
The firm's Diagnostics segment saw growth of 29 percent during the fourth quarter and 33 percent during the full year.
The George Washington University-led study uncovered increased neutrophil activity and decreased T cell activity among patients with severe COVID-19.
A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian.
Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports.
Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there.
In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.
Flatiron will curate real-world data from National Cancer Center Hospital East patients to build a database for research and treatment use.
The Abbott Park, Illinois-based firm's global COVID-19-related sales were $2.3 billion in the fourth quarter, including $2.1 billion from rapid testing.
In the first half of this year, the firm intends to launch a clinical study and begin the submission process to obtain FDA clearance for its colorectal cancer diagnostic test.
The move comes as the UK's Competition and Markets Authority cracks down on PCR test providers for price gouging and other improper business practices.
With the help of Mendelian randomization analyses, researchers saw signs that longevity coincides with reduced RNA polymerase- and ribosomal protein-coding gene expression.
A biobank-based study estimated the penetrance of a number of pathogenic genetic variants to find their risk of causing disease is low.